| Net Cash Provided by (Used in) Operating Activities |
-322,225 |
USD |
+45.5% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
263,873 |
USD |
-53.4% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
-3,485 |
USD |
|
Q1 2023 |
Q1 2024 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
691,528,945 |
shares |
+33.6% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-58,352 |
USD |
-1.3% |
Q1 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
114 |
USD |
0% |
Q1 2023 |
Q1 2023 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
17,351 |
USD |
|
Q1 2024 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
1,270,500 |
USD |
+1.9% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
1,270,500 |
USD |
+1.9% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
100,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
6,956,393 |
USD |
+1.5% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
100,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
23,914 |
USD |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |